On the use of PIPSA to Guide Target-Selective Drug Design
✍ Scribed by Stefan Henrich; Stefan Richter; Rebecca C. Wade
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 685 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1860-7179
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Overexpression of drug efflux transporters such as P-glycoprotein (P-gp) enables cancer cells to develop resistance to multiple anticancer drugs. Functional inhibitors of P-gp have shown promising efficacy in early clinical trials, but their long-term safety is yet to be established. A novel approac
A number of drugs act by inhibition of a specific target enzyme, thereby interfering with the synthesis of a key metabolite. When a specific enzyme inhibitor is applied to a functioning metabolic pathway, the substrate will accumulate and the inhibition will be counteracted, a phenomenon known as me